GPS News  
EPIDEMICS
Row erupts over Brazil suspension of Chinese vaccine trials
By Paula RAMON
Sao Paulo (AFP) Nov 10, 2020

Brazil's decision to halt trials of a Chinese-developed Covid-19 vaccine triggered a politically charged row Tuesday as a top health official expressed "indignation" and far-right President Jair Bolsonaro claimed the ruling as a personal victory.

Brazilian health regulator Anvisa announced late Monday it was suspending clinical trials of CoronaVac, developed by Chinese pharmaceutical firm Sinovac Biotech, after a "severe adverse incident" involving a volunteer in the study.

However, the public health center coordinating the trials in Brazil, the Butantan Institute, said there was no connection between the incident and the vaccine.

Privacy regulations prevent public health officials from disclosing details on the incident, which came as a setback for one of the most promising vaccines aiming to end the pandemic.

But the coroner's office that carried out an autopsy on the deceased volunteer's body told AFP police were investigating the death as a suicide.

"There is no relation with the vaccine," said Dimas Covas, head of the Butantan Institute, a respected public health center.

Anvisa's decision, he told a news conference, "came as a surprise... and caused indignation here at Butantan."

"We don't even know if this patient took the vaccine or a placebo," said the coordinator of the Sao Paulo state government's Covid-19 task force, Joao Gabbardo.

Sinovac also said the incident was unrelated to CoronaVac, adding it was "confident in the safety of the vaccine."

Anvisa chief Antonio Barra Torres told a separate news conference the agency had made a "technical decision" based on "incomplete and insufficient data" from the Butantan Institute on the cause of the incident.

- Vaccine politics -

CoronaVac has been caught up in a messy political battle in Brazil, where its most visible backer has been Sao Paulo Governor Joao Doria, a leading Bolsonaro opponent.

The president has thrown his support behind another vaccine, developed by Oxford University in Britain and the British-Swedish pharmaceutical firm AstraZeneca.

Bolsonaro and Doria have also sparred over whether vaccination should be mandatory.

The president, who has railed against CoronaVac as "Joao Doria's Chinese vaccine" and blocked the federal government from purchasing it, claimed the regulatory decision as vindication.

"Death, disability, malfunction. This is the vaccine Doria wants to require all Sao Paulo residents to receive," Bolsonaro wrote on Facebook.

"The president said this vaccine could never be mandatory. Chalk up another win for Jair Bolsonaro," he added.

Sao Paulo state has a deal with Sinovac to buy 46 million doses of CoronaVac -- six million produced in China and the rest produced in Sao Paulo, which broke ground last week on a factory to make the vaccine domestically.

The Sinovac and Oxford vaccines are both in Phase 3 trials, the final stage before regulatory approval.

Both are being tested in Brazil, the country with the second-highest death toll in the pandemic after the United States, with more than 162,000 people killed by the new coronavirus.

Brazil is also helping carry out Phase 3 testing of the vaccine developed by US pharmaceutical giant Pfizer and Germany's BioNTech.

Pfizer said Monday its vaccine had shown 90 percent effectiveness, unleashing a surge of optimism worldwide that an end to the pandemic could be within reach.

Bolsonaro faces criticism from experts for his handling of the pandemic, which has included playing down the virus, opposing lockdown measures and relentlessly promoting the drug hydroxychloroquine despite studies showing it is ineffective against Covid-19.

Opponents sharply criticized what they called his politicized handling of Monday's decision on CoronaVac.

"Prison is too light a punishment for these scums who play politics with vaccines, which are the only way out of the biggest public health and socioeconomic crisis in history," tweeted center-left politician Ciro Gomes, who ran against Bolsonaro in the 2018 presidential election.

pr-bur/jhb/dw

ASTRAZENECA

FACEBOOK

PFIZER

BioNTech


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
WHO urged to invite Taiwan to key meeting
Geneva (AFP) Nov 6, 2020
The World Health Organization is facing renewed pleas to allow Taiwan to participate in a key international meeting amid fears its exclusion could jeopardise efforts to rein in the coronavirus pandemic. As many parts of the world are reeling from surging numbers of Covid-19 infections and deaths, the WHO is due Monday to resume its main annual meeting, which was cut short in May. But while the World Health Assembly (WHA) is expected to focus heavily on international coordination of the pandemic ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
'Plantdemic' hits Philippines as demand for greenery grows

Parasitoid that targets Asian fruit fly is actually two distinct species

Food emissions could push Earth past global warming limits

Ecologically friendly agriculture doesn't compromise crop yields

EPIDEMICS
'Electronic skin' promises cheap and recyclable alternative to wearable devices

Tiny device enables new record in super-fast quantum light detection

Blue phosphorus: How a semiconductor becomes a metal

Next-generation computer chip with two heads

EPIDEMICS
Five female fighter pilots test G-force suits modified for women

Bye Aerospace signs key agreements with Aerospace9

Colleges, U.S. Air Force partner to improve diversity in STEM training

Berlin's much delayed new airport welcomes first flights

EPIDEMICS
Utilizing a 'krafty' waste product: Toward enhancing vehicle fuel economy

ULEMCo collaborates with JCB and Bucher to produce new hydrogen vehicle

GM says earnings jump 72%, cites improving auto demand in US, China

Greek island to shift to electric mobility with VW

EPIDEMICS
European gloom outweighs China boom for Richemont

China exports remain strong in October, import growth slows

German exports rise again in Sept as China demand soars

China's luxury shoppers call in the tidy teams

EPIDEMICS
Large trees dominate carbon storage in forests

Widest trees dominate carbon storage in Pacific Northwest forests

Researchers figure out how, why trees in the Amazon perish

China's most important trees are hiding in plain sight

EPIDEMICS
Detecting pollution from individual ships from space

ISS: 20 years looking over Earth

Climate change space project awarded to Airbus UK

Germany land motion mapped

EPIDEMICS
Researchers share design for affordable single-molecule microscope

Scientists explain the paradox of quantum forces in nanodevices

Rice rolls out next-gen nanocars

Nano particles for healthy tissue









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.